- Home
- YPF vs ROIV Comparison
YPF vs ROIV Comparison
Compare YPF & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YPF
- ROIV
- Stock Information
- Founded
- YPF 1977
- ROIV 2014
- Country
- YPF Argentina
- ROIV United Kingdom
- Employees
- YPF N/A
- ROIV N/A
- Industry
- YPF Integrated oil Companies
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- YPF Energy
- ROIV Health Care
- Exchange
- YPF Nasdaq
- ROIV Nasdaq
- Market Cap
- YPF 13.3B
- ROIV 7.8B
- IPO Year
- YPF 1993
- ROIV N/A
- Fundamental
- Price
- YPF $32.54
- ROIV $10.99
- Analyst Decision
- YPF Buy
- ROIV Buy
- Analyst Count
- YPF 7
- ROIV 4
- Target Price
- YPF $41.30
- ROIV $17.50
- AVG Volume (30 Days)
- YPF 1.7M
- ROIV 7.2M
- Earning Date
- YPF 08-08-2025
- ROIV 08-07-2025
- Dividend Yield
- YPF N/A
- ROIV N/A
- EPS Growth
- YPF N/A
- ROIV N/A
- EPS
- YPF 3.61
- ROIV N/A
- Revenue
- YPF $17,858,226,821.00
- ROIV $29,053,000.00
- Revenue This Year
- YPF $19.30
- ROIV $2.64
- Revenue Next Year
- YPF N/A
- ROIV $378.09
- P/E Ratio
- YPF $8.93
- ROIV N/A
- Revenue Growth
- YPF 131.82
- ROIV N/A
- 52 Week Low
- YPF $16.18
- ROIV $8.73
- 52 Week High
- YPF $47.43
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- YPF 40.45
- ROIV 44.89
- Support Level
- YPF $30.48
- ROIV $10.83
- Resistance Level
- YPF $33.87
- ROIV $11.82
- Average True Range (ATR)
- YPF 1.33
- ROIV 0.32
- MACD
- YPF -0.37
- ROIV -0.07
- Stochastic Oscillator
- YPF 26.48
- ROIV 16.75
About YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.